Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
news
2022-06-01 00:00:00

CARLSBAD, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ('Acutus' or the 'Company') (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on June 1, 2022 that were approved by the Compensation Committee of its Board of Directors under Company's 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 3 individuals hired by Acutus in May 2022. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
